Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 6
Submit an article Journal homepage
190
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Olverembatinib in relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: a study of 5 cases

Chunxiao Liua Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Xiang Zhanga Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Liping Maoa Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Jiejing Qiana Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Feng Xiaoa Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Xiujin Yea Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Juying Weia Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Xingnong Yea Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaView further author information
,
Jie Jina Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaCorrespondence[email protected]
View further author information
&
Wenjuan Yua Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;b Zhejiang Provincial Key Laboratory of Hematologic Malignancy, Zhejiang University, Hangzhou, PR China;c Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, PR China;d Zhejiang University Cancer Center, Hangzhou, PR ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1208-1211 | Received 29 Dec 2022, Accepted 25 Mar 2023, Published online: 17 Apr 2023
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Author contributions

Wenjuan Yu and Xiang Zhang designed this study. Liping Mao, Jiejing Qian, Feng Xiao, Xiujin Ye, Juying Wei, and Xingnong Ye collected and provided the clinical materials. Chunxiao Liu and Xiang Zhang integrated the clinical materials displayed the data analysis. Chunxiao Liu and Xiang Zhang wrote the manuscript. Jie Jin and Wenjuan Yu provided advices for this study and revised the manuscript. Chunxiao Liu and Xiang Zhang should be considered as the equally first authors. All authors approved the manuscript.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Additional information

Funding

This study was funded by the Natural Science Foundation of Zhejiang Province [LY21H080003], and the National Natural Science Foundation of China [81800199].

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.